Diego Cadavid's Net Worth
$793 Thousand
Who is Diego Cadavid?
Diego Cadavid does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Fulcrum Therapeutics, Inc., and X4 Pharmaceuticals, Inc.
SEC CIK
Diego Cadavid's CIK is 0001778713
Past Insider Trading and Trends
2020 was Diego Cadavid's most active year for acquiring shares with 11 total transactions. Diego Cadavid's most active month to acquire stocks was the month of May. 2020 was Diego Cadavid's most active year for disposing of shares, totalling 22 transactions. Diego Cadavid's most active month to dispose stocks was the month of May. 2020 saw Diego Cadavid paying a total of $808,196.40 for 182,520 shares, this is the most they've acquired in one year. In 2020 Diego Cadavid cashed out on 16,517 shares for a total of $205,754.52, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $7.9902
SVP Clinical Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.60% | -1.07K |
$18.30 | -$19,599.30 | 65.71K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$13.42 | -$25,051.03 | 66.78K |
Scheduled
|
Jun 25
| ||
Form 4
|
—
|
0
|
$13.42 | -$6,885.17 | 66.78K |
Scheduled
|
Jun 10
| ||
Form 4
|
—
|
0
|
$12.49 | -$10,362.12 | 66.78K |
Scheduled
|
Jun 4 - Jun 5
| ||
Form 4
|
—
|
0
|
$12.50 | -$5,869.70 | 66.78K |
Scheduled
|
Jun 2 - Jun 3
| ||
Form 4
|
—
|
0
|
$12.42 | -$12,143.00 | 66.78K |
Scheduled
|
May 28 - May 29
| ||
Form 4
|
—
|
0
|
$11.42 | -$24,496.20 | 66.78K |
Scheduled
|
May 12
| ||
Form 4
| -3.11% | -2.14K |
$17.38 | -$37,254.78 | 66.78K |
Scheduled
|
Mar 2
| ||
Form 4
| -3.02% | -2.14K |
$17.33 | -$37,141.83 | 68.93K |
Scheduled
|
Feb 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
X4 Pharmaceuticals, Inc (XFOR) Snapshot price: $0.86
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,364.85% | 97K |
—
|
—
| 104.11K |
Mar 1
| |||
Form 4
| -11.55% | -928.00 |
—
|
—
| 7.11K |
Scheduled
|
Feb 11
| ||
Form 4
|
∞
| 8.04K |
—
|
—
| 8.04K |
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||